Previous Article | Next Article 
J Virol, February 1998, p. 1606-1609, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Spike Protein of Murine Coronavirus Mouse
Hepatitis Virus Strain A59 Is Not Cleaved in Primary Glial Cells and
Primary Hepatocytes
Susan T.
Hingley,1
Isabelle
Leparc-Goffart,2,
and
Susan R.
Weiss2,*
Department of Microbiology and Immunology,
Philadelphia College of Osteopathic Medicine,1
and
Department of Microbiology, University of Pennsylvania
School of Medicine,2 Philadelphia, Pennsylvania
Received 7 August 1997/Accepted 16 October 1997
Mouse hepatitis virus strain A59 (MHV-A59) produces
meningoencephalitis and severe hepatitis during acute infection.
Infection of primary cells derived from the central nervous system
(CNS) and liver was examined to analyze the interaction of virus with individual cell types derived from the two principal sites of viral
replication in vivo. In glial cell cultures derived from C57BL/6 mice,
MHV-A59 produces a productive but nonlytic infection, with no evidence
of cell-to-cell fusion. In contrast, in continuously cultured cells,
this virus produces a lytic infection with extensive formation of
syncytia. The observation of few and delayed syncytia following MHV-A59
infection of hepatocytes more closely resembles infection of glial
cells than that of continuously cultured cell lines. For MHV-A59, lack
of syncytium formation correlates with lack of cleavage of the fusion
glycoprotein, or spike (S) protein. The absence of cell-to-cell fusion
following infection of both primary cell types prompted us to examine
the cleavage of the spike protein. Cleavage of S protein was below the
level of detection by Western blot analysis in MHV-A59-infected
hepatocytes and glial cells. Furthermore, no cleavage of this protein
was detected in liver homogenates from C57BL/6 mice infected with
MHV-A59. Thus, cleavage of the spike protein does not seem to be
essential for entry and spread of the virus in vivo, as well as for
replication in vitro.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Pennsylvania School of Medicine, 203A
Johnson Pavilion, 36th St. and Hamilton Walk, Philadelphia, PA
19104-6076. Phone: (215) 898-8013. Fax: (215) 573-4858. E-mail:
weisssr{at}mail.med.upenn.edu.
Present address: Division of Molecular Virology, Baylor College of
Medicine, Houston, TX 77030.
This article has been cited by other articles:
-
Qiu, Z., Hingley, S. T., Simmons, G., Yu, C., Das Sarma, J., Bates, P., Weiss, S. R.
(2006). Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated Entry.. J. Virol.
80: 5768-5776
[Abstract]
[Full Text]
-
Weiss, S. R., Navas-Martin, S.
(2005). Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol. Mol. Biol. Rev.
69: 635-664
[Abstract]
[Full Text]
-
Navas-Martin, S., Hingley, S. T., Weiss, S. R.
(2005). Murine Coronavirus Evolution In Vivo: Functional Compensation of a Detrimental Amino Acid Substitution in the Receptor Binding Domain of the Spike Glycoprotein. J. Virol.
79: 7629-7640
[Abstract]
[Full Text]
-
Sainz, B. Jr., Rausch, J. M., Gallaher, W. R., Garry, R. F., Wimley, W. C.
(2005). Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein. J. Virol.
79: 7195-7206
[Abstract]
[Full Text]
-
Ingallinella, P., Bianchi, E., Finotto, M., Cantoni, G., Eckert, D. M., Supekar, V. M., Bruckmann, C., Carfi, A., Pessi, A.
(2004). Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc. Natl. Acad. Sci. USA
101: 8709-8714
[Abstract]
[Full Text]
-
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., Bates, P.
(2004). Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA
101: 4240-4245
[Abstract]
[Full Text]
-
Bosch, B. J., van der Zee, R., de Haan, C. A. M., Rottier, P. J. M.
(2003). The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. J. Virol.
77: 8801-8811
[Abstract]
[Full Text]
-
Navas, S., Seo, S.-H., Chua, M. M., Sarma, J. D., Lavi, E., Hingley, S. T., Weiss, S. R.
(2001). Murine Coronavirus Spike Protein Determines the Ability of the Virus To Replicate in the Liver and Cause Hepatitis. J. Virol.
75: 2452-2457
[Abstract]
[Full Text]
-
Ito, H., Watanabe, S., Takada, A., Kawaoka, Y.
(2001). Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies. J. Virol.
75: 1576-1580
[Abstract]
[Full Text]
-
Wool-Lewis, R. J., Bates, P.
(1999). Endoproteolytic Processing of the Ebola Virus Envelope Glycoprotein: Cleavage Is Not Required for Function. J. Virol.
73: 1419-1426
[Abstract]
[Full Text]